Is chlorpromazine on the Beers (Potentially Inappropriate Medication) list?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Chlorpromazine on the Beers List?

Yes, chlorpromazine is on the Beers Criteria list as a potentially inappropriate medication for older adults, particularly when used for behavioral management in dementia, due to increased mortality risk and other serious adverse effects. 1, 2

Classification and Restrictions

Chlorpromazine is classified as an antipsychotic that should be avoided in older adults, especially for long-term management of cognitive behavioral problems in patients with dementia. 1 The American Geriatrics Society recommends avoiding antipsychotics in older adults due to increased mortality risk, particularly in patients with dementia. 2

Documented Risks

The use of chlorpromazine in older adults carries an FDA black box warning for increased mortality risk in those with dementing disorders. 1 Specific risks include:

  • Increased mortality in patients with dementia 1, 2
  • Delirium induction or worsening 1
  • Falls and fractures due to sedation and motor impairment 1
  • Cerebrovascular accidents (stroke) 1
  • Cognitive impairment and movement disorders 1

Acceptable Use Exceptions

The American Geriatrics Society permits chlorpromazine use only in limited, specific situations: 1

  • Short-term use during chemotherapy as an antiemetic
  • Treatment of schizophrenia
  • Management of acute delirium in controlled settings

Clinical Approach

First-line management should prioritize non-pharmacological approaches, including redirection techniques and environmental modifications for behavioral symptoms in older adults. 1, 2 If antipsychotic use becomes unavoidable, employ the shortest possible duration and conduct regular medication reviews using STOPP/START or Beers Criteria to identify deprescribing opportunities. 1, 2

When chlorpromazine is used for behavioral management and shows perceived lack of benefit, deprescribing is recommended, with safe tapering to discontinuation feasible in most cases. 1

Common Pitfalls

Avoid using chlorpromazine for routine behavioral management in dementia patients, as this represents the highest-risk scenario. 1, 2 The Beers Criteria should be applied systematically at every care transition to identify inappropriate antipsychotic use. 2, 3 Prioritize removal of antipsychotics when conducting medication rationalization, as they rank among medications with the highest morbidity and mortality risks. 2, 3

References

Guideline

Haloperidol Use in Older Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medication Management in Older Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Drug Rationalization in the Elderly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.